These results indicate that positive allosteric modulation of the M 4 muscarinic receptor could be a promising new strategy for treating schizophrenia, and that compounds such as LY2033298 might ...

a drug for schizophrenia that it thinks could have a clear side-effect profile than current therapies. The drug – a selective muscarinic M4 receptor positive allosteric modulator (PAM ...